DOT1L c.905C>T ;(p.S302L)

Variant ID: 19-2207621-C-T

NM_032482.2(DOT1L):c.905C>T;(p.S302L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Tumor RNA transfected DCs derived from iPS cells elicit cytotoxicity against cancer cells induced from colorectal cancer patients in vitro.

Scientific Reports
Maruoka, Shimpei S; Ojima, Toshiyasu T; Iwamoto, Hiromitsu H; Kitadani, Junya J; Tabata, Hirotaka H; Tominaga, Shinta S; Katsuda, Masahiro M; Hayata, Keiji K; Takeuchi, Akihiro A; Yamaue, Hiroki H
Publication Date: 2022-02-28

Variant appearance in text: DOT1L: S302L
PubMed Link: 35228610
Variant Present in the following documents:
  • 41598_2022_7305_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: DOT1L: S302L
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page